CSE:AGN - Post Discussion
Post by
stockpatrol on Jan 27, 2023 2:12pm
Algernon NeuroScience, a subsidiary of Algernon Pharmaceutic
Algernon NeuroScience, a subsidiary of Algernon Pharmaceuticals, has begun a Phase 1 clinical stroke study of DMT in the Netherlands, using a single-escalating dose design to determine a safe, non-psychedelic dose.
https://ca.finance.yahoo.com/news/algernon-pharmaceuticals-subsidiary-algernon-neuroscience-230000040.html
Be the first to comment on this post